Even Seoul-Area Tertiary Hospitals Fall Into the Red as 253 Institutions Record a Nine-Year Financial Slide
It is a familiar refrain in the healthcare industry that managing hospital finances has grown exceptionally difficult.
Search results for "drug costs"
As the U.S. Reconsiders Direct-to-Consumer Drug Ads, What Lessons Should We Learn?
During a yearlong stay in the United States, one of the things that struck me most was how easy it is to come across television and YouTube...
“We Can’t Afford Dad's Medicine”: The Heartbreaking Reality of Late-Stage Cancer Costs
“Should we sell the house? Dad’s medication is just too expensive.” This is the agonizing question keeping a mother in...
“I Dream of an Ordinary Life”: Expanded Insurance Coverage Brings New Hope to Dravet Syndrome Families
“Until just before my daughter turned 2, she frequently suffered not only febrile seizures but also afebrile seizures.
Robot-Assisted Operations Account for 1 in 5 Stomach Cancer Surgeries at Samsung Medical Center as Milestone Hits 1,500
Samsung Medical Center has performed more than 1,500 robot-assisted stomach cancer surgeries, reaching the milestone 16...
SK Plasma Launches High-Dose Revolpag 75 mg to Simplify Thrombocytopenia Regimens and Cut Costs
SK Plasma announced on Sept. 1 that it has begun distributing Revolpag Tablets 75 mg in South Korea, expanding its...
Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits
Pancreatic cancer remains one of the most formidable malignancies. Because early-stage disease rarely produces distinct...
From Retinal Scans to Brain Imaging: South Korea Backs Six Medical AI Tools for Fast-Track Hospital Adoption
Medical AI tools designed to assess cardiovascular risk from retinal images and analyze brain scans for stroke severity...
Samsung Medical Center Adopts Next-Generation Da Vinci 5 Robot to Advance Lung and Esophageal Cancer Surgery
Samsung Medical Center has introduced the latest robot-assisted surgery platform, the Da Vinci 5, for lung and...
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2
South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...